NCT02852954View on ClinicalTrials.gov

Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Progesterone Induced Blocking Factor in Endometrial Cancer
All Listed Sponsors
lead

Kayseri Education and Research Hospital

OTHER_GOV

NCT02852954 - Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells. | Biotech Hunter | Biotech Hunter